LRATD2 and neoplasm: To demonstrate whether the effect of FAM84B on tumor progression is mediated through the Wnt/β-catenin pathway, PANC-1 cells, which had lower FAM84B expression, were overexpressed with FAM84B and treated with XAV939, an inhibitor for the Wnt/β-catenin pathway [25].